Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.
about
Neglected filovirusesEbola and Marburg virus vaccines.Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.A thermostable, chromatographically purified Ebola nano-VLP vaccine.Development and Characterization of a Guinea Pig-Adapted Sudan Virus.Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesMacaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection.Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.Ebola vaccines in clinical trial: The promising candidates.Ebola virus vaccines - reality or fiction?Considerations for use of Ebola vaccine during an emergency response.Nonhuman Primate Models of Ebola Virus Disease.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Vaccines against 'the other' Ebolavirus species.Are RNA Viruses Candidate Agents for the Next Global Pandemic? A Review.Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model.Animal Models of Ebolavirus Infection
P2860
Q28383265-83271BC7-78B9-4899-A11B-85F8BA2F2266Q30234637-5FACBDDE-955F-4E66-8A8B-5E6BECECA4D6Q33826350-4A266BFA-E7E4-4B9D-9A74-323EC55D9C07Q35853669-BECB6310-AB9A-4522-B9DC-33C2C4FDBA0FQ36433906-8D87DD60-5A77-4186-B991-525551DAFE55Q36433920-A40B46BE-3652-4070-9FC4-B1EC5D4A420FQ36433965-2F931502-2EC1-45C4-B220-D22B26818381Q36493965-D8C6A165-F6DC-4E65-864C-79507F762D1BQ38674025-DA0DC952-674F-4376-A33E-7A7BDB15209EQ38741327-8FE2093C-8466-43A2-8994-343F73DB9F24Q38808678-39953BE2-7DA6-487D-8F06-B8AA0B4C949EQ38881265-139CF6E9-BF76-4F8D-B2F6-0F46247B36E1Q40039769-2A6E98F7-7B8A-400E-BDBD-F7FD48CFB622Q40051414-87FF60A8-53E2-4FA4-B324-492A604E271BQ40052567-D9509B6D-2813-4CAC-9770-338ACE404135Q40112699-B5A4EEFC-9E3F-4CEE-841C-00EA06AD18C1Q41922832-61EC22D3-A4A0-4C8C-B9C2-9014163048C7Q51784219-7E497052-4016-4CF4-B790-033DE0A4801AQ52678261-F9A1CFDF-386B-4E68-8F8A-0321DC08BCEFQ56541916-B648521B-DEBE-4BE3-9AFD-DFF07B47743A
P2860
Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Homologous and heterologous pr ...... nd Sudan virus-like particles.
@ast
Homologous and heterologous pr ...... nd Sudan virus-like particles.
@en
type
label
Homologous and heterologous pr ...... nd Sudan virus-like particles.
@ast
Homologous and heterologous pr ...... nd Sudan virus-like particles.
@en
prefLabel
Homologous and heterologous pr ...... nd Sudan virus-like particles.
@ast
Homologous and heterologous pr ...... nd Sudan virus-like particles.
@en
P2093
P2860
P1433
P1476
Homologous and heterologous pr ...... nd Sudan virus-like particles.
@en
P2093
Dana L Swenson
Frederick W Holtsberg
Jay B Wells
Kelly L Warfield
M Javad Aman
Robert C Unfer
Sergey Shulenin
P2860
P304
P356
10.1371/JOURNAL.PONE.0118881
P407
P577
2015-03-20T00:00:00Z